Answer
The treatment targets CD22, so the leukaemia must show CD22 expression using a validated sensitive test.
Sources for this answer
- BESPONSA 1 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.